Oracle Investment Management
Latest statistics and disclosures from Oracle Investment Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are WGS, BHVN, Select Sector Spdr Tr option, ARDX, SWTX, and represent 79.54% of Oracle Investment Management's stock portfolio.
- Added to shares of these 9 stocks: Select Sector Spdr Tr option (+$16M), SWTX (+$8.0M), BHVN (+$5.5M), ARDX, Teladoc Inc call, Springworks Therapeutics, Ardelyx Inc call, PLTR, FORA.
- Started 3 new stock positions in Select Sector Spdr Tr option, Teladoc Inc call, Springworks Therapeutics.
- Reduced shares in these 10 stocks: , PHAT, Biohaven, , Phathom Pharmaceuticals Inc call, Eyepoint Pharmaceuticals, WGS, PACB, PLTR, Novavax Inc call.
- Sold out of its positions in BDSX, Eyepoint Pharmaceuticals, MYGN, PLTR, Phathom Pharmaceuticals Inc call, Spdr S&p Oil & Gas Exp & Pr call.
- Oracle Investment Management was a net buyer of stock by $6.0M.
- Oracle Investment Management has $184M in assets under management (AUM), dropping by 10.06%.
- Central Index Key (CIK): 0001012622
Tip: Access up to 7 years of quarterly data
Positions held by Oracle Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 19 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Genedx Holdings Corp Com Cl A (WGS) | 42.8 | $79M | -2% | 1.0M | 76.86 |
|
| Biohaven (BHVN) | 17.3 | $32M | +20% | 852k | 37.35 |
|
| Select Sector Spdr Tr Put Put Option | 8.6 | $16M | NEW | 115k | 137.57 |
|
| Ardelyx (ARDX) | 5.8 | $11M | +52% | 2.1M | 5.07 |
|
| Springworks Therapeutics (SWTX) | 5.0 | $9.2M | +644% | 255k | 36.13 |
|
| Biohaven Call Call Option | 4.1 | $7.5M | -33% | 200k | 37.35 |
|
| Quidel Corp (QDEL) | 2.9 | $5.3M | 118k | 44.55 |
|
|
| BioCryst Pharmaceuticals (BCRX) | 2.2 | $4.0M | 536k | 7.52 |
|
|
| Novavax Call Call Option | 2.0 | $3.7M | -12% | 466k | 8.04 |
|
| Ardelyx Call Call Option | 1.6 | $3.0M | +35% | 585k | 5.07 |
|
| Forian Ord (FORA) | 1.5 | $2.8M | 1.4M | 2.06 |
|
|
| Teladoc Health Call Call Option | 1.5 | $2.7M | NEW | 298k | 9.09 |
|
| Palantir Technologies Cl A (PLTR) | 1.2 | $2.2M | +3% | 29k | 75.63 |
|
| Cava Group Ord (CAVA) | 1.1 | $2.1M | 19k | 112.80 |
|
|
| Springworks Therapeutics Call Call Option | 1.1 | $2.0M | NEW | 56k | 36.13 |
|
| Phathom Pharmaceuticals (PHAT) | 0.6 | $1.2M | -80% | 145k | 8.12 |
|
| Pacific Biosciences of California (PACB) | 0.3 | $512k | -61% | 280k | 1.83 |
|
| Biogen Idec (BIIB) | 0.2 | $369k | 2.4k | 152.92 |
|
|
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.1 | $242k | 33k | 7.45 |
|
Past Filings by Oracle Investment Management
SEC 13F filings are viewable for Oracle Investment Management going back to 2010
- Oracle Investment Management 2024 Q4 filed Feb. 14, 2025
- Oracle Investment Management 2024 Q3 filed Nov. 14, 2024
- Oracle Investment Management 2024 Q2 filed Aug. 14, 2024
- Oracle Investment Management 2024 Q1 filed May 15, 2024
- Oracle Investment Management 2023 Q4 filed Feb. 14, 2024
- Oracle Investment Management 2023 Q3 filed Nov. 14, 2023
- Oracle Investment Management 2023 Q2 filed Aug. 14, 2023
- Oracle Investment Management 2023 Q1 filed May 15, 2023
- Oracle Investment Management 2022 Q4 filed Feb. 14, 2023
- Oracle Investment Management 2022 Q3 filed Nov. 14, 2022
- Oracle Investment Management 2022 Q2 filed Aug. 15, 2022
- Oracle Investment Management 2022 Q1 filed May 16, 2022
- Oracle Investment Management 2021 Q4 filed Feb. 14, 2022
- Oracle Investment Management 2021 Q3 filed Nov. 15, 2021
- Oracle Investment Management 2021 Q2 filed Aug. 16, 2021
- Oracle Investment Management 2021 Q1 filed May 17, 2021